Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 15.768
Filtrer
1.
AAPS PharmSciTech ; 25(6): 149, 2024 Jul 01.
Article de Anglais | MEDLINE | ID: mdl-38954224

RÉSUMÉ

Silibinin (SIL) Encapsulated Nanoliquid Crystalline (SIL-NLCs) particles were prepared to study neuroprotective effect against amyloid beta (Aß1-42) neurotoxicity in Balb/c mice model. Theses NLCs were prepared through hot emulsification and probe sonication technique. The pharmacodynamics was investigatigated on Aß1-42 intracerebroventricular (ICV) injected Balb/c mice. The particle size, zeta potential and drug loading were optimized to be 153 ± 2.5 nm, -21 mV, and 8.2%, respectively. Small angle X-ray (SAXS) and electron microscopy revealed to crystalline shape of SIL-NLCs. Thioflavin T (ThT) fluroscence and circular dichroism (CD) technique were employed to understand monomer inhibition effect of SIL-NLCs on Aß1-4. In neurobehavioral studies, SIL-NLCs exhibited enhanced mitigation of memory impairment induced on by Aß1-42 in T-maze and new object recognition test (NORT). Whereas biochemical and histopathological estimation of brain samples showed reduction in level of Aß1-42 aggregate, acetylcholine esterase (ACHE) and reactive oxygen species (ROS). SIL-NLCs treated animal group showed higher protection against Aß1-42 toxicity compared to free SIL and Donopezil (DPZ). Therefore SIL-NLCs promises great prospect in neurodegenerative diseases such as Alzheimer's disease.


Sujet(s)
Peptides bêta-amyloïdes , Souris de lignée BALB C , Neuroprotecteurs , Fragments peptidiques , Silibinine , Animaux , Peptides bêta-amyloïdes/toxicité , Peptides bêta-amyloïdes/métabolisme , Souris , Silibinine/pharmacologie , Silibinine/administration et posologie , Fragments peptidiques/toxicité , Neuroprotecteurs/pharmacologie , Neuroprotecteurs/administration et posologie , Mâle , Encéphale/effets des médicaments et des substances chimiques , Encéphale/métabolisme , Encéphale/anatomopathologie , Taille de particule , Nanoparticules/composition chimique , Espèces réactives de l'oxygène/métabolisme , Modèles animaux de maladie humaine , Maladie d'Alzheimer/traitement médicamenteux , Maladie d'Alzheimer/métabolisme , Acetylcholinesterase/métabolisme
2.
BMC Res Notes ; 17(1): 188, 2024 Jul 05.
Article de Anglais | MEDLINE | ID: mdl-38970085

RÉSUMÉ

Heavy metals are encountered in nature, and are used in several human endeavors, including in dental fillings. It is well known that the safety of metals depends on their chemical form, as well as the dose and route through which biological systems are exposed to them. Here, we used the Nauphoeta cinerea model to examine the mechanism by which salts of the heavy metals used in dental fillings - silver and mercury - exert their neurotoxicity. Nymphs exposed to heavy metals presented with reduced motor and exploratory abilities as they spent more time immobile, especially in the periphery of a novel object, and covered less distance compared with control nymphs. Exposure to AgNO3 and HgCl2 also exacerbated levels of oxidative stress markers (MDA & ROS) and the neurotransmitter regulators - AChE and MAO, while reducing antioxidant activity markers, both in biochemical (thiol & GST) and RT-qPCR (TRX, GST, SOD, Catalase) examinations, in neural tissues of the cockroach. The observed disruptions in neurolocomotor control, synaptic transmission and redox balance explain how heavy metal salts may predispose organisms to neurological disorders.


Sujet(s)
Oxydoréduction , Stress oxydatif , Animaux , Oxydoréduction/effets des médicaments et des substances chimiques , Stress oxydatif/effets des médicaments et des substances chimiques , Mercure/toxicité , Argent/pharmacologie , Argent/toxicité , Agents neuromédiateurs/métabolisme , Acetylcholinesterase/métabolisme , Nymphe/effets des médicaments et des substances chimiques , Nymphe/métabolisme , Monoamine oxidase/métabolisme , Comportement animal/effets des médicaments et des substances chimiques , Espèces réactives de l'oxygène/métabolisme , Nitrate d'argent/pharmacologie , Chlorure de mercure II/toxicité
3.
J Biochem Mol Toxicol ; 38(7): e23750, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38952032

RÉSUMÉ

The treatment of organophosphate (OP) anticholinesterases currently lacks an effective oxime reactivator of OP-inhibited acetylcholinesterase (AChE) which can penetrate the blood-brain barrier (BBB). Our laboratories have synthesized novel substituted phenoxyalkyl pyridinium oximes and tested them for their ability to promote survival of rats challenged with lethal doses of nerve agent surrogates. These previous studies demonstrated the ability of some of these oximes to promote 24-h survival to rats challenged with a lethal level of highly relevant surrogates for sarin and VX. The reactivation of OP-inhibited AChE in peripheral tissues was likely to be a major contributor to their efficacy in survival of lethal OP challenges. In the present study, twenty of these novel oximes were screened in vitro for reactivation ability for AChE in rat skeletal muscle and serum using two nerve agent surrogates: phthalimidyl isopropyl methylphosphonate (PIMP, a sarin surrogate) and 4-nitrophenyl ethyl methylphosphonate (NEMP, a VX surrogate). The oximes demonstrated a range of 23%-102% reactivation of AChE in vitro across both tissue types. Some of the novel oximes tested in the present study demonstrated the ability to more effectively reactivate AChE in serum than the currently approved oxime, 2-PAM. Therefore, some of these novel oximes have the potential to reverse AChE inhibition in peripheral target tissues and contribute to survival efficacy.


Sujet(s)
Acetylcholinesterase , Anticholinestérasiques , Réactivateurs de la cholinestérase , Muscles squelettiques , Organophosphates , Oximes , Animaux , Oximes/pharmacologie , Oximes/composition chimique , Rats , Acetylcholinesterase/métabolisme , Acetylcholinesterase/sang , Muscles squelettiques/effets des médicaments et des substances chimiques , Muscles squelettiques/enzymologie , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/toxicité , Organophosphates/toxicité , Mâle , Réactivateurs de la cholinestérase/pharmacologie , Réactivateurs de la cholinestérase/composition chimique , Composés de pyridinium/pharmacologie , Rat Sprague-Dawley
4.
Sci Rep ; 14(1): 16325, 2024 Jul 15.
Article de Anglais | MEDLINE | ID: mdl-39009775

RÉSUMÉ

Mosquitoes are important vectors for the transmission of several infectious diseases that lead to huge morbidity and mortality. The exhaustive use of synthetic insecticides has led to widespread resistance and environmental pollution. Using essential oils and nano-emulsions as novel insecticides is a promising alternative approach for controlling vector borne diseases. In the current study, Lantana camara EO and NE were evaluated for their larvicidal and pupicidal activities against Anopheles culicifacies. The inhibitory effect of EO and NE on AChE, NSE (α/ß), and GST was also evaluated and compared. GC-MS analysis of oil displayed 61 major peaks. The stable nano-emulsion with an observed hydrodynamic diameter of 147.62 nm was formed using the o/w method. The nano-emulsion exhibited good larvicidal (LC50 50.35 ppm and LC90 222.84 ppm) and pupicidal (LC50 54.82 ppm and LC90 174.58 ppm) activities. Biochemical evaluations revealed that LCEO and LCNE inhibited AChE, NSE (α/ß), and GST, displaying LCNE to be a potent binder to AChE and NSE enzyme, whereas LCEO showed higher binding potency towards GST. The nano-emulsion provides us with novel opportunities to target different mosquito enzymes with improved insecticidal efficacy. Due to its natural origin, it can be further developed as a safer and more potent larvicide/insecticide capable of combating emerging insecticide resistance.


Sujet(s)
Anopheles , Émulsions , Insecticides , Lantana , Larve , Huile essentielle , Anopheles/effets des médicaments et des substances chimiques , Huile essentielle/pharmacologie , Huile essentielle/composition chimique , Animaux , Lantana/composition chimique , Insecticides/pharmacologie , Insecticides/composition chimique , Larve/effets des médicaments et des substances chimiques , Cinétique , Acetylcholinesterase/métabolisme , Glutathione transferase/métabolisme , Glutathione transferase/antagonistes et inhibiteurs , Vecteurs moustiques/effets des médicaments et des substances chimiques , Antienzymes/pharmacologie , Antienzymes/composition chimique , Lutte contre les moustiques/méthodes
5.
Sci Rep ; 14(1): 16427, 2024 Jul 16.
Article de Anglais | MEDLINE | ID: mdl-39013912

RÉSUMÉ

The ecotoxicological consequences of azoxystrobin on land snails have not yet been addressed. Therefore, the present study aims to provide novel data on the threat of a commercial grade azoxystrobin (AMISTAR) at two environmentally relevant concentrations (0.3 µg/ml) and tenfold (3 µg/ml) on the model species, Theba pisana by physiological, biochemical, and histopathological markers for 28 days. Our results showed a reduction in animal food consumption and growth due to exposure to both azoxystrobin concentrations. It also induced oxidative stress and led to a significant decrease in lipid peroxidation (LPO) levels after 7 days of exposure, while the opposite effect occurred after 28 days. Except for the 7-day exposure, all treated snails had significantly reduced glutathione (GSH) content and increased catalase (CAT) activity at all-time intervals. Glutathione peroxidase (GPx), glutathione-S-transferase (GST) activities, and protein content (PC) were elevated in treated snails at all-time intervals. Moreover, alterations in acetylcholinesterase (AChE) activity between a decrease and an increase were noticed. Additionally, azoxystrobin exerted changes in T. pisana hepatopancreas architecture. Our study suggests that azoxystrobin may have negative ecological consequences for T. pisana and highlights its potential risks to the natural environment.


Sujet(s)
Fongicides industriels , Glutathion , Méthacrylates , Stress oxydatif , Pyrimidines , Escargots , Strobilurines , Animaux , Strobilurines/toxicité , Pyrimidines/toxicité , Stress oxydatif/effets des médicaments et des substances chimiques , Fongicides industriels/toxicité , Méthacrylates/toxicité , Escargots/effets des médicaments et des substances chimiques , Escargots/métabolisme , Glutathion/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Glutathione transferase/métabolisme , Acetylcholinesterase/métabolisme , Écotoxicologie , Catalase/métabolisme , Glutathione peroxidase/métabolisme
6.
Bioorg Chem ; 150: 107598, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-38959645

RÉSUMÉ

A completely green protocol was developed for the synthesis of a series of arylaminonaphthol derivatives in the presence of N-ethylethanolamine (NEEA) as a catalyst under ultrasonic irradiation and solventless conditions. The major assets of this methodology were the use of non-toxic organic medium, available catalyst, mild reaction condition, and good to excellent yield of desired products. All of the synthesized products were screened for their in vitro antioxidant activity using DPPH, ABTS, and Ferric-phenanthroline assays and it was found that most of them are potent antioxidant agents. Also, their butyrylcholinesterase inhibitory activity has been investigated in vitro. All tested compounds exhibited potential inhibitory activity toward BuChE when compared to standard reference drug galantamine, however, compounds 4r, 4u, 4 g and 4x gave higher butyrylcholinesterase inhibitory with IC50 values of 14.78 ± 0.65 µM, 16.18 ± 0.50 µM, 20.00 ± 0.50 µM, and 20.28 ± 0.08 µM respectively. On the other hand, we employed density functional theory (DFT), calculations to analyze molecular geometry and global reactivity descriptors, and MESP analysis to predict electrophilic and nucleophilic attacks. A quantitative structure-activity relationship (QSAR) investigation was conducted on the antioxidant and butyrylcholinesterase properties of 25 arylaminonaphthol derivatives, resulting in robust and satisfactory models. To evaluate their anti-Alzheimer's activity, compounds 4 g, 4q, 4r, 4u, and 4x underwent docking simulations at the active site of the acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), revealing why these compounds displayed superior activity, consistent with the biological findings.


Sujet(s)
Antioxydants , Butyrylcholine esterase , Anticholinestérasiques , Simulation de docking moléculaire , Relation quantitative structure-activité , Butyrylcholine esterase/métabolisme , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/synthèse chimique , Anticholinestérasiques/composition chimique , Antioxydants/pharmacologie , Antioxydants/synthèse chimique , Antioxydants/composition chimique , Structure moléculaire , Humains , Relation dose-effet des médicaments , Acetylcholinesterase/métabolisme
7.
Bioorg Chem ; 150: 107584, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-38964146

RÉSUMÉ

Developing multitargeted ligands as promising therapeutics for Alzheimer's disease (AD) has been considered important. Herein, a novel class of cinnamamide/ester-triazole hybrids with multifaceted effects on AD was developed based on the multitarget-directed ligands strategy. Thirty-seven cinnamamide/ester-triazole hybrids were synthesized, with most exhibiting significant inhibitory activity against Aß-induced toxicity at a single concentration in vitro. The most optimal hybrid compound 4j inhibited copper-induced Aß toxicity in AD cells. its action was superior to that of donepezil and memantine. It also moderately inhibited intracellular AChE activity and presented favorable bioavailability and blood-brain barrier penetration with low toxicity in vivo. Of note, it ameliorated cognitive impairment, neuronal degeneration, and Aß deposition in Aß1-42-injured mice. Mechanistically, the compound regulated APP processing by promoting the ADAM10-associated nonamyloidogenic signaling and inhibiting the BACE1-mediated amyloidogenic pathway. Moreover, it suppressed intracellular AChE activity and tau phosphorylation. Therefore, compound 4j may be a promising multitargeted active molecule against AD.


Sujet(s)
Maladie d'Alzheimer , Peptides bêta-amyloïdes , Cinnamates , Triazoles , Maladie d'Alzheimer/traitement médicamenteux , Maladie d'Alzheimer/métabolisme , Animaux , Triazoles/composition chimique , Triazoles/pharmacologie , Triazoles/synthèse chimique , Cinnamates/composition chimique , Cinnamates/pharmacologie , Cinnamates/synthèse chimique , Humains , Souris , Peptides bêta-amyloïdes/métabolisme , Peptides bêta-amyloïdes/antagonistes et inhibiteurs , Relation structure-activité , Structure moléculaire , Esters/composition chimique , Esters/pharmacologie , Esters/synthèse chimique , Relation dose-effet des médicaments , Acetylcholinesterase/métabolisme , Anticholinestérasiques/composition chimique , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/synthèse chimique , Découverte de médicament , Neuroprotecteurs/composition chimique , Neuroprotecteurs/pharmacologie , Neuroprotecteurs/synthèse chimique , Fragments peptidiques/métabolisme , Fragments peptidiques/antagonistes et inhibiteurs , Mâle
8.
Bioorg Chem ; 150: 107591, 2024 Sep.
Article de Anglais | MEDLINE | ID: mdl-38964147

RÉSUMÉ

Some heterocycles bearing a benzo[h]quinoline moiety were synthesized through treating a 3-((2-chlorobenzo[h]quinolin-3-yl)methylene)-5-(p-tolyl)furan-2(3H)-one with four nitrogen nucleophiles comprising ammonium acetate, benzylamine, dodecan-1-amine, and 1,2-diaminoethane. Also, thiation reactions of furanone and pyrrolinone derivatives were investigated. The insecticidal activity of these compounds against mosquito larvae (Culex pipiens L.) was evaluated. All tested compounds exhibited significant larvicidal activity, surpassing that of the conventional insecticide chlorpyrifos. In silico docking analysis revealed that these compounds may act as acetyl cholinesterase (AChE) inhibitors, potentially explaining their larvicidal effect. Additionally, interactions with other neuroreceptors, such as nicotinic acetylcholine receptor and sodium channel voltage-gated alpha subunit were also predicted. The results obtained from this study reflected the potential of benzo[h]quinoline derivatives as promising candidates for developing more effective and sustainable mosquito control strategies. The ADME (absorption, distribution, metabolism, and excretion) analyses displayed their desirable drug-likeness and oral bioavailability properties.


Sujet(s)
Culex , Insecticides , Larve , Simulation de docking moléculaire , Quinoléines , Animaux , Culex/effets des médicaments et des substances chimiques , Insecticides/pharmacologie , Insecticides/composition chimique , Insecticides/synthèse chimique , Larve/effets des médicaments et des substances chimiques , Relation structure-activité , Quinoléines/pharmacologie , Quinoléines/composition chimique , Quinoléines/synthèse chimique , Structure moléculaire , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/synthèse chimique , Anticholinestérasiques/composition chimique , Relation dose-effet des médicaments , Acetylcholinesterase/métabolisme
9.
Sci Rep ; 14(1): 15577, 2024 Jul 06.
Article de Anglais | MEDLINE | ID: mdl-38971857

RÉSUMÉ

Alzheimer's disease is the most prevalent neurodegenerative disorder characterized by significant memory loss and cognitive impairments. Studies have shown that the expression level and activity of the butyrylcholinesterase enzyme increases significantly in the late stages of Alzheimer's disease, so butyrylcholinesterase can be considered as a promising therapeutic target for potential Alzheimer's treatments. In the present study, a novel series of 2,4-disubstituted quinazoline derivatives (6a-j) were synthesized and evaluated for their inhibitory activities against acetylcholinesterase (AChE) and butyrylcholinestrase (BuChE) enzymes, as well as for their antioxidant activities. The biological evaluation revealed that compounds 6f, 6h, and 6j showed potent inhibitory activities against eqBuChE, with IC50 values of 0.52, 6.74, and 3.65 µM, respectively. These potent compounds showed high selectivity for eqBuChE over eelAChE. The kinetic study demonstrated a mixed-type inhibition pattern for both enzymes, which revealed that the potent compounds might be able to bind to both the catalytic active site and peripheral anionic site of eelAChE and eqBuChE. In addition, molecular docking studies and molecular dynamic simulations indicated that potent compounds have favorable interactions with the active sites of BuChE. The antioxidant screening showed that compounds 6b, 6c, and 6j displayed superior scavenging capabilities compared to the other compounds. The obtained results suggest that compounds 6f, 6h, and 6j are promising lead compounds for the further development of new potent and selective BuChE inhibitors.


Sujet(s)
Antioxydants , Butyrylcholine esterase , Anticholinestérasiques , Simulation de docking moléculaire , Simulation de dynamique moléculaire , Quinazolines , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/synthèse chimique , Anticholinestérasiques/composition chimique , Butyrylcholine esterase/métabolisme , Butyrylcholine esterase/composition chimique , Antioxydants/pharmacologie , Antioxydants/composition chimique , Antioxydants/synthèse chimique , Quinazolines/pharmacologie , Quinazolines/composition chimique , Quinazolines/synthèse chimique , Acetylcholinesterase/métabolisme , Acetylcholinesterase/composition chimique , Humains , Relation structure-activité , Domaine catalytique , Animaux , Cinétique , Electrophorus
10.
Protein Sci ; 33(8): e5100, 2024 Aug.
Article de Anglais | MEDLINE | ID: mdl-39022909

RÉSUMÉ

Cholinesterases are well-known and widely studied enzymes crucial to human health and involved in neurology, Alzheimer's, and lipid metabolism. The protonation pattern of active sites of cholinesterases influences all the chemical processes within, including reaction, covalent inhibition by nerve agents, and reactivation. Despite its significance, our comprehension of the fine structure of cholinesterases remains limited. In this study, we employed enhanced-sampling quantum-mechanical/molecular-mechanical calculations to show that cholinesterases predominantly operate as dynamic mixtures of two protonation states. The proton transfer between two non-catalytic glutamate residues follows the Grotthuss mechanism facilitated by a mediator water molecule. We show that this uncovered complexity of active sites presents a challenge for classical molecular dynamics simulations and calls for special treatment. The calculated proton transfer barrier of 1.65 kcal/mol initiates a discussion on the potential existence of two coupled low-barrier hydrogen bonds in the inhibited form of butyrylcholinesterase. These findings expand our understanding of structural features expressed by highly evolved enzymes and guide future advances in cholinesterase-related protein and drug design studies.


Sujet(s)
Butyrylcholine esterase , Domaine catalytique , Simulation de dynamique moléculaire , Protons , Butyrylcholine esterase/composition chimique , Butyrylcholine esterase/métabolisme , Humains , Liaison hydrogène , Acetylcholinesterase/composition chimique , Acetylcholinesterase/métabolisme , Cholinesterases/composition chimique , Cholinesterases/métabolisme
11.
Int J Mol Sci ; 25(13)2024 Jun 28.
Article de Anglais | MEDLINE | ID: mdl-39000210

RÉSUMÉ

Neurodegeneration diseases (NDs) are a group of complex diseases primarily characterized by progressive loss of neurons affecting mental function and movement. Oxidative stress is one of the factors contributing to the pathogenesis of NDs, including Alzheimer's disease (AD). These reactive species disturb mitochondrial function and accelerate other undesirable conditions including tau phosphorylation, inflammation, and cell death. Therefore, preventing oxidative stress is one of the imperative methods in the treatment of NDs. To accomplish this, we prepared hexane and ethyl acetate extracts of Anethum graveolens (dill) and identified the major phyto-components (apiol, carvone, and dihydrocarvone) by GC-MS. The extracts and major bioactives were assessed for neuroprotective potential and mechanism in hydrogen peroxide-induced oxidative stress in the SH-SY5Y neuroblastoma cell model and other biochemical assays. The dill (extracts and bioactives) provided statistically significant neuroprotection from 0.1 to 30 µg/mL by mitigating ROS levels, restoring mitochondrial membrane potential, reducing lipid peroxidation, and reviving the glutathione ratio. They moderately inhibited acetylcholine esterase (IC50 dill extracts 400-500 µg/mL; carvone 275.7 µg/mL; apiole 388.3 µg/mL), displayed mild anti-Aß1-42 fibrilization (DHC 26.6%) and good anti-oligomerization activity (>40% by dill-EA, carvone, and apiole). Such multifactorial neuroprotective displayed by dill and bioactives would help develop a safe, low-cost, and small-molecule drug for NDs.


Sujet(s)
Anethum graveolens , Neuroblastome , Neuroprotecteurs , Stress oxydatif , Extraits de plantes , Graines , Humains , Neuroprotecteurs/pharmacologie , Neuroprotecteurs/composition chimique , Lignée cellulaire tumorale , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Neuroblastome/métabolisme , Neuroblastome/traitement médicamenteux , Neuroblastome/anatomopathologie , Stress oxydatif/effets des médicaments et des substances chimiques , Anethum graveolens/composition chimique , Graines/composition chimique , Potentiel de membrane mitochondriale/effets des médicaments et des substances chimiques , Peptides bêta-amyloïdes/métabolisme , Peroxydation lipidique/effets des médicaments et des substances chimiques , Espèces réactives de l'oxygène/métabolisme , Peroxyde d'hydrogène , Composés phytochimiques/pharmacologie , Composés phytochimiques/composition chimique , Survie cellulaire/effets des médicaments et des substances chimiques , Acetylcholinesterase/métabolisme
12.
Int J Mol Sci ; 25(13)2024 Jul 03.
Article de Anglais | MEDLINE | ID: mdl-39000410

RÉSUMÉ

Alzheimer's disease (AD) is a multifactorial and fatal neurodegenerative disorder. Acetylcholinesterase (AChE) plays a key role in the regulation of the cholinergic system and particularly in the formation of amyloid plaques; therefore, the inhibition of AChE has become one of the most promising strategies for the treatment of AD, particularly concerning AChE inhibitors that interact with the peripheral anionic site (PAS). Ceanothic acid isolated from the Chilean Rhamnaceae plants is an inhibitor of AChE through its interaction with PAS. In this study, six ceanothic acid derivatives were prepared, and all showed inhibitory activity against AChE. The structural modifications were performed starting from ceanothic acid by application of simple synthetic routes: esterification, reduction, and oxidation. AChE activity was determined by the Ellmann method for all compounds. Kinetic studies indicated that its inhibition was competitive and reversible. According to the molecular coupling and displacement studies of the propidium iodide test, the inhibitory effect of compounds would be produced by interaction with the PAS of AChE. In silico predictions of physicochemical properties, pharmacokinetics, drug-likeness, and medicinal chemistry friendliness of the ceanothane derivatives were performed using the Swiss ADME tool.


Sujet(s)
Acetylcholinesterase , Domaine catalytique , Anticholinestérasiques , Conception de médicament , Anticholinestérasiques/composition chimique , Anticholinestérasiques/pharmacologie , Acetylcholinesterase/composition chimique , Acetylcholinesterase/métabolisme , Humains , Maladie d'Alzheimer/traitement médicamenteux , Cinétique , Simulation de docking moléculaire , Relation structure-activité , Anions/composition chimique , Animaux
13.
Int J Mol Sci ; 25(13)2024 Jul 05.
Article de Anglais | MEDLINE | ID: mdl-39000508

RÉSUMÉ

The targeted compounds in this research, resveratrol analogs 1-14, were synthesized as mixtures of isomers by the Wittig reaction using heterocyclic triphenylphosphonium salts and various benzaldehydes. The planned compounds were those possessing the trans-configuration as the biologically active trans-resveratrol. The pure isomers were obtained by repeated column chromatography in various isolated yields depending on the heteroaromatic ring. It was found that butyrylcholinesterase (BChE) was more sensitive to the heteroaromatic resveratrol analogs than acetylcholinesterase (AChE), except for 6, the methylated thiophene derivative with chlorine, which showed equal inhibition toward both enzymes. Compounds 5 and 8 achieved the highest BChE inhibition with IC50 values of 22.9 and 24.8 µM, respectively. The same as with AChE and BChE, methylated thiophene subunits of resveratrol analogs showed better enzyme inhibition than unmethylated ones. Two antioxidant spectrophotometric methods, DPPH and CUPRAC, were applied to determine the antioxidant potential of new heteroaromatic resveratrol analogs. The molecular docking of these compounds was conducted to visualize the ligand-active site complexes' structure and identify the non-covalent interactions responsible for the complex's stability, which influence the inhibitory potential. As ADME properties are crucial in developing drug product formulations, they have also been addressed in this work. The potential genotoxicity is evaluated by in silico studies for all compounds synthesized.


Sujet(s)
Antioxydants , Butyrylcholine esterase , Anticholinestérasiques , Simulation de docking moléculaire , Resvératrol , Resvératrol/analogues et dérivés , Resvératrol/composition chimique , Resvératrol/pharmacologie , Resvératrol/synthèse chimique , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/composition chimique , Anticholinestérasiques/synthèse chimique , Antioxydants/composition chimique , Antioxydants/pharmacologie , Antioxydants/synthèse chimique , Butyrylcholine esterase/métabolisme , Butyrylcholine esterase/composition chimique , Acetylcholinesterase/métabolisme , Acetylcholinesterase/composition chimique , Humains , Relation structure-activité
14.
Molecules ; 29(13)2024 Jun 27.
Article de Anglais | MEDLINE | ID: mdl-38999004

RÉSUMÉ

Depression and anxiety are recognized as the most common mental diseases worldwide. New approaches have considered different therapeutic targets, such as oxidative stress and the inflammation process, due to their close association with the establishment and progression of mental diseases. In the present study, we evaluated the antioxidant and anti-inflammatory activities of the methanolic extracts of the plant species Heteropterys brachiata and Heteropterys cotinifolia and their main compounds, chlorogenic acid and rutin, as potential complementary therapeutic tools for the treatment of anxiety and depression, since the antidepressant and anxiolytic activities of these methanolic extracts have been shown previously. Additionally, we also evaluated their inhibitory activity on the enzyme acetylcholinesterase (AChE). Our results revealed that both species exhibited potent antioxidant activity (>90%) through the TBARS assay, while by means of the DPPH assay, only H. cotinifolia exerted potent antioxidant activity (>90%); additionally, low metal chelating activity (<40%) was detected for all samples tested in the ferrozine assay. The methanolic extracts of H. brachiata and H. cotinifolia exhibited significant anti-inflammatory activities in the TPA-induced ear edema, while only H. cotinifolia exerted significant anti-inflammatory activities in the MPO assay (>45%) and also exhibited a higher percentage of inhibition on AChE of even twice (>80%) as high as the control in concentrations of 100 and 1000 µg/mL. Thus, the potent antioxidant and inflammatory properties and the inhibition of AChE may be involved in the antidepressant activities of the species H. cotinifolia, which would be positioned as a candidate for study in drug development as an alternative in the treatment of depression.


Sujet(s)
Anti-inflammatoires , Antioxydants , Extraits de plantes , Antioxydants/pharmacologie , Antioxydants/composition chimique , Extraits de plantes/pharmacologie , Extraits de plantes/composition chimique , Anti-inflammatoires/pharmacologie , Anti-inflammatoires/composition chimique , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/composition chimique , Animaux , Acetylcholinesterase/métabolisme , Antidépresseurs/pharmacologie , Antidépresseurs/composition chimique , Antidépresseurs/usage thérapeutique , Souris , Mexique
15.
Chem Biol Drug Des ; 104(1): e14592, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-39013758

RÉSUMÉ

Neuroinflammation is suggested as one of the potential links between CS-induced neuronal dysfunction. Cigarette smoke (CS) is one of the significant contributors of neuroinflammation, consequently leading to cognitive impairment and neurodegeneration. Microglia are the key resident macrophage cells in the brain with cell surface TLR4 receptor for responding to various stress signals. The CS constituents promote inflammation and oxidative stress in microglia leading to cytotoxicity through the TLR4-MK2 axis. However, the role of MK2 kinase in CS-induced microglial inflammation is not yet clearly understood. Therefore, we have used an MK2 inhibitor, PF-3644022 to study modulation of CS-extract induced oxidative and inflammatory signaling in a mouse microglial cell line, Furthermore, we also evaluated the enzymatic activity of acetylcholinesterase (AChE) on a direct exposure of enzyme with CS. CS exposure led to microglial cytotoxicity and enhanced the level of oxidative stress and proinflammatory cytokine release by microglial cells. The microglial cells pretreated with MK2 inhibitor, PF-3644022 significantly reduced the levels of oxidative stress markers, proinflammatory markers, and improved the level of antioxidant proteins in these cells. In addition, direct exposure of CS showed reduction in the enzymatic activity of AChE.


Sujet(s)
Acetylcholinesterase , Microglie , Stress oxydatif , Protein-Serine-Threonine Kinases , Animaux , Microglie/métabolisme , Microglie/effets des médicaments et des substances chimiques , Souris , Stress oxydatif/effets des médicaments et des substances chimiques , Lignée cellulaire , Protein-Serine-Threonine Kinases/métabolisme , Protein-Serine-Threonine Kinases/antagonistes et inhibiteurs , Acetylcholinesterase/métabolisme , Protéines et peptides de signalisation intracellulaire/métabolisme , Protéines et peptides de signalisation intracellulaire/antagonistes et inhibiteurs , Fumée/effets indésirables , Cytokines/métabolisme , Survie cellulaire/effets des médicaments et des substances chimiques , Nicotiana/composition chimique
16.
Physiol Rep ; 12(13): e16095, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38946616

RÉSUMÉ

The present study aimed to investigate the effect of catechin-loaded Chitosan-Alginate nanoparticles (NPs) on cognitive function in an aluminum chloride (AlCl3)-induced rat model of Alzheimer's disease (AD). The Catechin-loaded Chitosan-Alginate nanocarriers were synthesized through ionotropic gelation (IG) method. Physio-chemical characterization was conducted with the Zetasizer Nano system, the scanning electron microscope, and the Fourier transform infrared spectroscopy. The experiments were performed over 21 days on six groups of male Wistar rats. The control group, AlCl3 treated group, Catechin group, nanocarrier group, treatment group 1 (AlCl3 + Catechin), and treatment group 2 (AlCl3 + nanocarrier). A behavioral study was done by the Morris water maze (MWM) test. In addition, the level of oxidative indices and acetylcholine esterase (AChE) activity was determined by standard procedures at the end of the study. AlCl3 induced a significant increase in AChE activity, along with a significant decrease in the level of Catalase (CAT) and total antioxidant capacity (TAC) in the hippocampus. Moreover, the significant effect of AlCl3 was observed on the behavioral parameters of the MWM test. Both forms of Catechin markedly improved AChE activity, oxidative biomarkers, spatial memory, and learning. The present study indicated that the administration of Catechin-loaded Chitosan-Alginate NPs is a beneficial therapeutic option against behavioral and chemical alteration of AD in male Wistar rats.


Sujet(s)
Alginates , Chlorure d'aluminium , Maladie d'Alzheimer , Catéchine , Chitosane , Nanoparticules , Rat Wistar , Animaux , Catéchine/administration et posologie , Catéchine/pharmacologie , Chlorure d'aluminium/toxicité , Chitosane/composition chimique , Chitosane/administration et posologie , Alginates/composition chimique , Alginates/administration et posologie , Mâle , Maladie d'Alzheimer/traitement médicamenteux , Maladie d'Alzheimer/induit chimiquement , Maladie d'Alzheimer/métabolisme , Rats , Administration par voie orale , Cognition/effets des médicaments et des substances chimiques , Acetylcholinesterase/métabolisme , Apprentissage du labyrinthe/effets des médicaments et des substances chimiques , Hippocampe/effets des médicaments et des substances chimiques , Hippocampe/métabolisme , Modèles animaux de maladie humaine , Antioxydants/pharmacologie , Antioxydants/administration et posologie , Stress oxydatif/effets des médicaments et des substances chimiques , Vecteurs de médicaments/composition chimique
17.
J Sep Sci ; 47(14): e2400288, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-39034832

RÉSUMÉ

Dalbergia odorifera is a natural product rich in pharmacological ingredients, but the comprehensive characterization and rapid profiling of active components remain a challenge. Thus, an integrated data mining and identification strategy was exploited to efficiently identify the chemical constituents and screen acetylcholinesterase inhibitors (AChEIs) through affinity ultrafiltration and ultra-high-performance liquid chromatography-mass spectrometry (AUF-UHPLC-MS). As a result, polygonal mass defect filtering, diagnostic product ions, and neutral loss rules were created for rapid structural classification and component identification. A total of 140 flavonoids were tentatively characterized, including 41 isoflavonoids, 23 flavanones, 21 isoflavans, 19 flavones and flavonols, 13 neoflavonoids, 11 isoflavanones, seven flavone glycosides, and five chalcones. Subsequently, six natural AChEIs including tectorigenin, fisetin, dalbergin, pterostilbene, isoliquiritigenin, and biochanin A were screened out using AUF-UHPLC-MS and molecular docking. Meanwhile, the AChE inhibitory activities of the six compounds were assessed in vitro, tectorigenin, fisetinand, and dalbergin have moderate inhibitory activity. In conclusion, a novel strategy for systematic characterization and further screening of active compounds in natural products was established, which provides a material basis for quality control of Dalbergia odorifera.


Sujet(s)
Anticholinestérasiques , Dalbergia , Spectrométrie de masse en tandem , Ultrafiltration , Anticholinestérasiques/composition chimique , Anticholinestérasiques/analyse , Dalbergia/composition chimique , Chromatographie en phase liquide à haute performance , Acetylcholinesterase/composition chimique , Acetylcholinesterase/métabolisme , Simulation de docking moléculaire , Flavonoïdes/composition chimique , Flavonoïdes/analyse , Structure moléculaire , Extraits de plantes/composition chimique
18.
Aquat Toxicol ; 272: 106971, 2024 Jul.
Article de Anglais | MEDLINE | ID: mdl-38843741

RÉSUMÉ

Bisphenol A (BPA), a common industrial chemical with estrogenic activity, has recently gained attention due to its well-documented negative effects on humans and other organisms in the environment. The potential immunotoxicity and neurotoxicity of BPA remain poorly understood in marine invertebrate species. Therefore, the impacts of exposure to BPA on a series of behaviours, immune responses, oxidative stress, neural biomarkers, histology, and the ultrastructure of gills were investigated in the date mussel, Lithophaga lithophaga. After 28 days of exposure to 0.25, 1, 2, and 5 µg/L BPA, hemolymphs from controls and exposed date mussels were collected, and the effects of BPA on immunological parameters were evaluated. Moreover, oxidative stress and neurochemical levels were measured in the gills of L. lithophaga. BPA reduced filtration rates and burrowing behaviour, whereas a 2 µg/L BPA resulted in an insignificant increase after 24 h. The exposure of date mussels to BPA significantly increased total hemocyte counts, a significant reduction in the diameter and phagocytosis of hemocytes, as well as gill lysozyme level. BPA increased lipid peroxidation levels and SOD activity in gills exposed to 2 and 5 µg/L BPA, but decreased GSH levels and SOD activity in 0.25 and 1 µg/L BPA-treated date mussels. Dose-dependent dynamics were observed in the inhibition of acetylcholinesterase activity and dopamine levels. Histological and scanning electron microscope examination revealed cilia erosion, necrosis, inflammation, and hyperplasia formation in the gills. Overall, our findings suggest a relationship between BPA exposure and changes in the measured immune parameters, oxidative stress, and neurochemical disturbances, which may be factored into the mechanisms underlying BPA toxicity in marine molluscs, providing a scientific foundation for marine BPA risk assessment and indicating immunosuppression in BPA-exposed date mussels.


Sujet(s)
Acetylcholinesterase , Composés benzhydryliques , Dopamine , Branchies , Hémocytes , Stress oxydatif , Phénols , Polluants chimiques de l'eau , Animaux , Branchies/effets des médicaments et des substances chimiques , Phénols/toxicité , Hémocytes/effets des médicaments et des substances chimiques , Composés benzhydryliques/toxicité , Polluants chimiques de l'eau/toxicité , Acetylcholinesterase/métabolisme , Dopamine/métabolisme , Stress oxydatif/effets des médicaments et des substances chimiques , Bivalvia/effets des médicaments et des substances chimiques , Comportement animal/effets des médicaments et des substances chimiques , Anticholinestérasiques/toxicité , Peroxydation lipidique/effets des médicaments et des substances chimiques
19.
Molecules ; 29(11)2024 May 23.
Article de Anglais | MEDLINE | ID: mdl-38893333

RÉSUMÉ

Alzheimer's disease (AD) and diabetes are non-communicable diseases with global impacts. Inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are suitable therapies for AD, while α-amylase and α-glucosidase inhibitors are employed as antidiabetic agents. Compounds were isolated from the medicinal plant Terminalia macroptera and evaluated for their AChE, BChE, α-amylase, and α-glucosidase inhibitions. From 1H and 13C NMR data, the compounds were identified as 3,3'-di-O-methyl ellagic acid (1), 3,3',4'-tri-O-methyl ellagic acid-4-O-ß-D-xylopyranoside (2), 3,3',4'-tri-O-methyl ellagic acid-4-O-ß-D-glucopyranoside (3), 3,3'-di-O-methyl ellagic acid-4-O-ß-D-glucopyranoside (4), myricetin-3-O-rhamnoside (5), shikimic acid (6), arjungenin (7), terminolic acid (8), 24-deoxysericoside (9), arjunglucoside I (10), and chebuloside II (11). The derivatives of ellagic acid (1-4) showed moderate to good inhibition of cholinesterases, with the most potent being 3,3'-di-O-methyl ellagic acid, with IC50 values of 46.77 ± 0.90 µg/mL and 50.48 ± 1.10 µg/mL against AChE and BChE, respectively. The compounds exhibited potential inhibition of α-amylase and α-glucosidase, especially the phenolic compounds (1-5). Myricetin-3-O-rhamnoside had the highest α-amylase inhibition with an IC50 value of 65.17 ± 0.43 µg/mL compared to acarbose with an IC50 value of 32.25 ± 0.36 µg/mL. Two compounds, 3,3'-di-O-methyl ellagic acid (IC50 = 74.18 ± 0.29 µg/mL) and myricetin-3-O-rhamnoside (IC50 = 69.02 ± 0.65 µg/mL), were more active than the standard acarbose (IC50 = 87.70 ± 0.68 µg/mL) in the α-glucosidase assay. For α-glucosidase and α-amylase, the molecular docking results for 1-11 reveal that these compounds may fit well into the binding sites of the target enzymes, establishing stable complexes with negative binding energies in the range of -4.03 to -10.20 kcalmol-1. Though not all the compounds showed binding affinities with cholinesterases, some had negative binding energies, indicating that the inhibition was thermodynamically favorable.


Sujet(s)
Acetylcholinesterase , Anticholinestérasiques , Hypoglycémiants , Simulation de docking moléculaire , Extraits de plantes , Terminalia , alpha-Amylases , Anticholinestérasiques/pharmacologie , Anticholinestérasiques/composition chimique , Hypoglycémiants/composition chimique , Hypoglycémiants/pharmacologie , Extraits de plantes/composition chimique , Extraits de plantes/pharmacologie , alpha-Amylases/antagonistes et inhibiteurs , alpha-Amylases/métabolisme , Acetylcholinesterase/métabolisme , Acetylcholinesterase/composition chimique , Terminalia/composition chimique , Humains , Butyrylcholine esterase/métabolisme , alpha-Glucosidase/métabolisme , alpha-Glucosidase/composition chimique , Inhibiteurs des glycoside hydrolases/pharmacologie , Inhibiteurs des glycoside hydrolases/composition chimique , Structure moléculaire
20.
Molecules ; 29(11)2024 May 23.
Article de Anglais | MEDLINE | ID: mdl-38893334

RÉSUMÉ

Thiazolin-4-ones and their derivatives represent important heterocyclic scaffolds with various applications in medicinal chemistry. For that reason, the synthesis of two 5-substituted thiazolidin-4-one derivatives was performed. Their structure assignment was conducted by NMR experiments (2D-COSY, 2D-NOESY, 2D-HSQC and 2D-HMBC) and conformational analysis was conducted through Density Functional Theory calculations and 2D-NOESY. Conformational analysis showed that these two molecules adopt exo conformation. Their global minimum structures have two double bonds (C=N, C=C) in Z conformation and the third double (C=N) in E. Our DFT results are in agreement with the 2D-NMR measurements. Furthermore, the reaction isomerization paths were studied via DFT to check the stability of the conformers. Finally, some potential targets were found through the SwissADME platform and docking experiments were performed. Both compounds bind strongly to five macromolecules (triazoloquinazolines, mglur3, Jak3, Danio rerio HDAC6 CD2, acetylcholinesterase) and via SwissADME it was found that these two molecules obey Lipinski's Rule of Five.


Sujet(s)
Conformation moléculaire , Simulation de docking moléculaire , Thiazolidines , Thiazolidines/composition chimique , Thiazolidines/synthèse chimique , Isomérie , Animaux , Acetylcholinesterase/composition chimique , Acetylcholinesterase/métabolisme , Danio zébré , Spectroscopie par résonance magnétique , Janus kinase 3/antagonistes et inhibiteurs , Janus kinase 3/métabolisme , Janus kinase 3/composition chimique , Structure moléculaire
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE